| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cesarean Section | 30 | 2024 | 387 | 5.260 |
Why?
|
| Embolism, Amniotic Fluid | 12 | 2020 | 31 | 4.880 |
Why?
|
| Heart Rate, Fetal | 14 | 2022 | 62 | 4.850 |
Why?
|
| Maternal Mortality | 20 | 2020 | 80 | 4.570 |
Why?
|
| Pregnancy | 119 | 2024 | 7179 | 4.300 |
Why?
|
| Hypertension, Pregnancy-Induced | 8 | 2024 | 74 | 4.000 |
Why?
|
| Pregnancy Complications | 17 | 2024 | 512 | 3.850 |
Why?
|
| Obstetrics | 16 | 2019 | 238 | 3.660 |
Why?
|
| Delivery, Obstetric | 16 | 2024 | 251 | 3.150 |
Why?
|
| Venous Thromboembolism | 9 | 2024 | 165 | 3.080 |
Why?
|
| Postpartum Hemorrhage | 12 | 2024 | 96 | 2.820 |
Why?
|
| Pregnancy Complications, Cardiovascular | 7 | 2019 | 104 | 2.420 |
Why?
|
| Pre-Eclampsia | 8 | 2022 | 221 | 2.250 |
Why?
|
| Obstetric Labor Complications | 7 | 2018 | 92 | 2.100 |
Why?
|
| Fetal Monitoring | 7 | 2022 | 56 | 2.090 |
Why?
|
| Labor, Obstetric | 8 | 2021 | 94 | 1.970 |
Why?
|
| Placenta Accreta | 12 | 2024 | 157 | 1.740 |
Why?
|
| Labor, Induced | 5 | 2014 | 34 | 1.690 |
Why?
|
| Female | 122 | 2024 | 66482 | 1.690 |
Why?
|
| Oxytocin | 4 | 2014 | 69 | 1.430 |
Why?
|
| Gestational Age | 14 | 2024 | 1158 | 1.390 |
Why?
|
| Pulmonary Embolism | 6 | 2015 | 177 | 1.280 |
Why?
|
| Cardiotocography | 3 | 2021 | 19 | 1.270 |
Why?
|
| Reproductive Techniques, Assisted | 3 | 2021 | 70 | 1.230 |
Why?
|
| Blood Loss, Surgical | 5 | 2024 | 154 | 1.230 |
Why?
|
| Humans | 126 | 2024 | 124593 | 1.220 |
Why?
|
| Maternal Death | 3 | 2016 | 8 | 1.200 |
Why?
|
| Pregnancy Outcome | 12 | 2021 | 588 | 1.180 |
Why?
|
| Intracranial Hemorrhages | 3 | 2014 | 75 | 1.150 |
Why?
|
| Oxytocics | 5 | 2014 | 28 | 1.140 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2018 | 728 | 1.110 |
Why?
|
| Antihypertensive Agents | 6 | 2024 | 411 | 1.100 |
Why?
|
| Heparin, Low-Molecular-Weight | 2 | 2017 | 23 | 1.080 |
Why?
|
| Gynecology | 3 | 2017 | 123 | 1.050 |
Why?
|
| Placenta Previa | 7 | 2024 | 65 | 1.030 |
Why?
|
| Prenatal Care | 4 | 2020 | 347 | 1.010 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 4 | 2016 | 16 | 1.010 |
Why?
|
| Guideline Adherence | 5 | 2016 | 380 | 1.000 |
Why?
|
| Premature Birth | 4 | 2020 | 385 | 0.960 |
Why?
|
| Extraction, Obstetrical | 3 | 2016 | 9 | 0.950 |
Why?
|
| Malpractice | 3 | 2011 | 55 | 0.940 |
Why?
|
| Patient Safety | 5 | 2016 | 399 | 0.930 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2024 | 42 | 0.910 |
Why?
|
| United States | 33 | 2020 | 10887 | 0.890 |
Why?
|
| Apgar Score | 3 | 2021 | 47 | 0.870 |
Why?
|
| Clinical Protocols | 6 | 2015 | 240 | 0.850 |
Why?
|
| Pregnancy Complications, Hematologic | 3 | 2021 | 28 | 0.810 |
Why?
|
| Healthcare Disparities | 2 | 2017 | 429 | 0.780 |
Why?
|
| Infant, Newborn | 23 | 2024 | 8189 | 0.770 |
Why?
|
| Thymus Neoplasms | 1 | 2022 | 39 | 0.760 |
Why?
|
| Quality Assurance, Health Care | 6 | 2019 | 206 | 0.750 |
Why?
|
| Anticoagulants | 4 | 2024 | 588 | 0.740 |
Why?
|
| Clinical Decision-Making | 3 | 2018 | 266 | 0.740 |
Why?
|
| Umbilical Arteries | 1 | 2021 | 95 | 0.720 |
Why?
|
| Postoperative Complications | 5 | 2019 | 3065 | 0.720 |
Why?
|
| Hysterectomy | 8 | 2022 | 191 | 0.720 |
Why?
|
| Practice Guidelines as Topic | 10 | 2024 | 1267 | 0.710 |
Why?
|
| Brachial Plexus | 1 | 2021 | 20 | 0.710 |
Why?
|
| Radiologic Health | 1 | 2020 | 1 | 0.700 |
Why?
|
| Delivery of Health Care | 4 | 2019 | 607 | 0.700 |
Why?
|
| Surgical Procedures, Operative | 2 | 2020 | 183 | 0.690 |
Why?
|
| Algorithms | 6 | 2017 | 1619 | 0.680 |
Why?
|
| Acidosis | 2 | 2021 | 93 | 0.670 |
Why?
|
| Quality of Health Care | 6 | 2019 | 389 | 0.660 |
Why?
|
| Abortion, Spontaneous | 1 | 2020 | 79 | 0.640 |
Why?
|
| Cholecystectomy | 1 | 2019 | 58 | 0.640 |
Why?
|
| Stillbirth | 3 | 2018 | 80 | 0.620 |
Why?
|
| Shock | 1 | 2020 | 90 | 0.620 |
Why?
|
| Antisepsis | 1 | 2018 | 9 | 0.620 |
Why?
|
| Povidone-Iodine | 1 | 2018 | 10 | 0.610 |
Why?
|
| Adult | 35 | 2024 | 29438 | 0.610 |
Why?
|
| Hospitals | 2 | 2019 | 388 | 0.610 |
Why?
|
| Peer Review | 2 | 2016 | 39 | 0.610 |
Why?
|
| Obstetrical Forceps | 2 | 2016 | 8 | 0.610 |
Why?
|
| Chlorhexidine | 1 | 2018 | 45 | 0.600 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2016 | 81 | 0.590 |
Why?
|
| Intermittent Pneumatic Compression Devices | 2 | 2015 | 4 | 0.590 |
Why?
|
| Evidence-Based Medicine | 5 | 2024 | 635 | 0.590 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 276 | 0.590 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2018 | 71 | 0.580 |
Why?
|
| Liability, Legal | 1 | 2018 | 44 | 0.580 |
Why?
|
| Research Design | 3 | 2018 | 691 | 0.580 |
Why?
|
| Heart Arrest | 3 | 2019 | 351 | 0.570 |
Why?
|
| Hypoxia | 2 | 2016 | 247 | 0.570 |
Why?
|
| Women's Health Services | 1 | 2017 | 14 | 0.570 |
Why?
|
| Risk Factors | 16 | 2024 | 10270 | 0.560 |
Why?
|
| Blood Coagulation Disorders | 4 | 2021 | 103 | 0.560 |
Why?
|
| Birth Injuries | 2 | 2008 | 22 | 0.560 |
Why?
|
| Ethanol | 1 | 2018 | 163 | 0.550 |
Why?
|
| Term Birth | 3 | 2017 | 32 | 0.550 |
Why?
|
| Professional Staff Committees | 1 | 2016 | 6 | 0.540 |
Why?
|
| Retrospective Studies | 28 | 2024 | 16314 | 0.540 |
Why?
|
| Maternal-Child Health Services | 1 | 2016 | 13 | 0.540 |
Why?
|
| Infertility, Female | 1 | 2017 | 144 | 0.530 |
Why?
|
| Birth Certificates | 1 | 2016 | 13 | 0.530 |
Why?
|
| Amniotic Fluid | 1 | 2017 | 150 | 0.530 |
Why?
|
| Perinatal Care | 2 | 2016 | 67 | 0.520 |
Why?
|
| Maternal Health Services | 3 | 2019 | 37 | 0.510 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2019 | 314 | 0.510 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 260 | 0.510 |
Why?
|
| Postnatal Care | 2 | 2015 | 51 | 0.510 |
Why?
|
| Patient Care Bundles | 1 | 2015 | 22 | 0.490 |
Why?
|
| Hypertension | 2 | 2022 | 1320 | 0.490 |
Why?
|
| Simulation Training | 2 | 2019 | 139 | 0.480 |
Why?
|
| Education, Nursing | 1 | 2015 | 12 | 0.470 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2015 | 54 | 0.470 |
Why?
|
| Hospitalists | 1 | 2015 | 45 | 0.460 |
Why?
|
| Maternal Age | 5 | 2020 | 134 | 0.460 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2016 | 169 | 0.460 |
Why?
|
| Blood Component Transfusion | 5 | 2021 | 55 | 0.450 |
Why?
|
| Prenatal Diagnosis | 4 | 2021 | 597 | 0.450 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2017 | 450 | 0.440 |
Why?
|
| Blood Transfusion | 4 | 2021 | 309 | 0.430 |
Why?
|
| Magnesium Sulfate | 2 | 2011 | 49 | 0.420 |
Why?
|
| Epithelial Cells | 1 | 2017 | 909 | 0.420 |
Why?
|
| Elective Surgical Procedures | 2 | 2011 | 159 | 0.410 |
Why?
|
| Escherichia coli Infections | 1 | 2015 | 195 | 0.410 |
Why?
|
| Blood Gas Analysis | 3 | 2021 | 83 | 0.410 |
Why?
|
| beta-Lactamases | 1 | 2015 | 197 | 0.410 |
Why?
|
| Infant, Low Birth Weight | 2 | 2011 | 167 | 0.400 |
Why?
|
| Nursing Staff, Hospital | 1 | 2013 | 54 | 0.400 |
Why?
|
| Biometry | 1 | 2013 | 136 | 0.390 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2013 | 79 | 0.390 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2015 | 364 | 0.390 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2014 | 314 | 0.370 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 437 | 0.370 |
Why?
|
| Patient Compliance | 1 | 2015 | 471 | 0.370 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 2024 | 61 | 0.370 |
Why?
|
| Lung | 2 | 2017 | 1491 | 0.360 |
Why?
|
| Medical Errors | 1 | 2012 | 155 | 0.350 |
Why?
|
| Oxygen | 2 | 2021 | 553 | 0.350 |
Why?
|
| Checklist | 3 | 2017 | 85 | 0.350 |
Why?
|
| Biomedical Research | 1 | 2016 | 517 | 0.350 |
Why?
|
| Dystocia | 2 | 2008 | 23 | 0.350 |
Why?
|
| Fetal Death | 3 | 2018 | 112 | 0.350 |
Why?
|
| Quality Improvement | 1 | 2016 | 639 | 0.350 |
Why?
|
| Diagnosis, Differential | 5 | 2018 | 1882 | 0.340 |
Why?
|
| Consensus | 4 | 2019 | 646 | 0.340 |
Why?
|
| Placenta Diseases | 2 | 2022 | 59 | 0.330 |
Why?
|
| Postpartum Period | 2 | 2010 | 215 | 0.320 |
Why?
|
| Neuroprotective Agents | 1 | 2011 | 157 | 0.320 |
Why?
|
| Group Practice | 1 | 2009 | 11 | 0.320 |
Why?
|
| Infant, Premature, Diseases | 1 | 2011 | 242 | 0.310 |
Why?
|
| Compensation and Redress | 1 | 2008 | 12 | 0.310 |
Why?
|
| Intraoperative Complications | 2 | 2021 | 172 | 0.310 |
Why?
|
| Sleep Deprivation | 1 | 2009 | 50 | 0.300 |
Why?
|
| Uterine Contraction | 1 | 2008 | 28 | 0.300 |
Why?
|
| Sensitivity and Specificity | 5 | 2021 | 2050 | 0.300 |
Why?
|
| Fetal Hypoxia | 2 | 2011 | 14 | 0.300 |
Why?
|
| Vacuum Extraction, Obstetrical | 1 | 2008 | 3 | 0.300 |
Why?
|
| Infant, Premature | 2 | 2011 | 812 | 0.290 |
Why?
|
| Placenta | 5 | 2022 | 506 | 0.290 |
Why?
|
| Pregnancy Trimester, Third | 3 | 2019 | 118 | 0.280 |
Why?
|
| Clinical Competence | 2 | 2016 | 998 | 0.270 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 375 | 0.270 |
Why?
|
| Shoulder | 1 | 2006 | 29 | 0.270 |
Why?
|
| Fetal Diseases | 1 | 2011 | 455 | 0.270 |
Why?
|
| Young Adult | 8 | 2020 | 9014 | 0.260 |
Why?
|
| Fetus | 2 | 2021 | 585 | 0.260 |
Why?
|
| Oximetry | 1 | 2007 | 162 | 0.250 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 1813 | 0.250 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2019 | 432 | 0.250 |
Why?
|
| Vena Cava Filters | 1 | 2005 | 21 | 0.250 |
Why?
|
| Labetalol | 2 | 2020 | 12 | 0.240 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2021 | 90 | 0.240 |
Why?
|
| Thromboembolism | 1 | 2005 | 89 | 0.240 |
Why?
|
| Cesarean Section, Repeat | 1 | 2024 | 8 | 0.240 |
Why?
|
| Labor Stage, Second | 2 | 2021 | 16 | 0.230 |
Why?
|
| Uterine Hemorrhage | 2 | 2019 | 43 | 0.230 |
Why?
|
| Cohort Studies | 6 | 2022 | 4795 | 0.230 |
Why?
|
| Patient Selection | 2 | 2020 | 693 | 0.230 |
Why?
|
| Cerebrovascular Circulation | 3 | 2020 | 432 | 0.230 |
Why?
|
| Registries | 3 | 2020 | 1424 | 0.220 |
Why?
|
| Vaginal Birth after Cesarean | 2 | 2018 | 23 | 0.220 |
Why?
|
| Enoxaparin | 1 | 2024 | 41 | 0.220 |
Why?
|
| Value of Life | 1 | 2003 | 9 | 0.210 |
Why?
|
| Erythrocyte Transfusion | 3 | 2019 | 129 | 0.210 |
Why?
|
| Infusions, Intravenous | 3 | 2020 | 547 | 0.210 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2024 | 80 | 0.210 |
Why?
|
| Perineum | 3 | 2021 | 48 | 0.200 |
Why?
|
| Prospective Studies | 9 | 2021 | 6135 | 0.200 |
Why?
|
| Time Factors | 4 | 2018 | 6292 | 0.200 |
Why?
|
| Emergency Service, Hospital | 1 | 2010 | 1087 | 0.200 |
Why?
|
| Antirheumatic Agents | 1 | 2024 | 125 | 0.200 |
Why?
|
| Pregnancy Trimesters | 2 | 2021 | 34 | 0.200 |
Why?
|
| Pregnancy, Twin | 2 | 2021 | 180 | 0.200 |
Why?
|
| Eclampsia | 2 | 2020 | 29 | 0.190 |
Why?
|
| Risk Assessment | 4 | 2020 | 3441 | 0.190 |
Why?
|
| Infant Mortality | 3 | 2016 | 174 | 0.190 |
Why?
|
| Labor Presentation | 1 | 2021 | 10 | 0.190 |
Why?
|
| Cerebral Palsy | 1 | 2003 | 79 | 0.190 |
Why?
|
| Urologic Diseases | 1 | 2021 | 44 | 0.180 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2024 | 262 | 0.180 |
Why?
|
| Fetal Distress | 2 | 2016 | 12 | 0.180 |
Why?
|
| Ovulation Induction | 1 | 2021 | 41 | 0.180 |
Why?
|
| Incidence | 4 | 2022 | 3138 | 0.180 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2021 | 968 | 0.180 |
Why?
|
| Nifedipine | 1 | 2020 | 21 | 0.170 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 505 | 0.170 |
Why?
|
| Blood Coagulation | 1 | 2021 | 123 | 0.170 |
Why?
|
| History, 21st Century | 2 | 2014 | 267 | 0.170 |
Why?
|
| Risk Adjustment | 1 | 2020 | 58 | 0.170 |
Why?
|
| Case-Control Studies | 4 | 2019 | 3281 | 0.170 |
Why?
|
| Referral and Consultation | 2 | 2015 | 541 | 0.170 |
Why?
|
| Patient Care Team | 3 | 2019 | 542 | 0.160 |
Why?
|
| Vasa Previa | 1 | 2019 | 9 | 0.160 |
Why?
|
| Remission, Spontaneous | 1 | 2019 | 69 | 0.160 |
Why?
|
| Hospital Administration | 1 | 2019 | 23 | 0.160 |
Why?
|
| Cause of Death | 2 | 2014 | 473 | 0.160 |
Why?
|
| Fetal Hemoglobin | 1 | 2019 | 28 | 0.160 |
Why?
|
| Bicarbonates | 1 | 2019 | 98 | 0.160 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 3424 | 0.160 |
Why?
|
| Obstetric Labor, Premature | 1 | 2019 | 85 | 0.150 |
Why?
|
| Nomograms | 1 | 2019 | 36 | 0.150 |
Why?
|
| Perinatology | 1 | 2019 | 32 | 0.150 |
Why?
|
| Fertilization in Vitro | 1 | 2020 | 147 | 0.150 |
Why?
|
| Administration, Cutaneous | 1 | 2018 | 66 | 0.150 |
Why?
|
| Birth Weight | 4 | 2022 | 346 | 0.150 |
Why?
|
| Fetal Blood | 1 | 2019 | 176 | 0.150 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 126 | 0.140 |
Why?
|
| Prognosis | 4 | 2019 | 4625 | 0.140 |
Why?
|
| Fetal Mortality | 1 | 2017 | 7 | 0.140 |
Why?
|
| Drug Combinations | 1 | 2018 | 267 | 0.140 |
Why?
|
| Episiotomy | 1 | 2017 | 16 | 0.140 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 197 | 0.140 |
Why?
|
| Cell Count | 1 | 2017 | 252 | 0.140 |
Why?
|
| Learning Curve | 1 | 2017 | 53 | 0.140 |
Why?
|
| Health Status Indicators | 1 | 2017 | 122 | 0.140 |
Why?
|
| Epidemics | 1 | 2017 | 54 | 0.130 |
Why?
|
| Birth Rate | 1 | 2016 | 16 | 0.130 |
Why?
|
| Peripartum Period | 1 | 2016 | 31 | 0.130 |
Why?
|
| Benchmarking | 1 | 2017 | 134 | 0.130 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2017 | 63 | 0.130 |
Why?
|
| Preoperative Care | 1 | 2018 | 354 | 0.130 |
Why?
|
| Medical Records | 2 | 2014 | 189 | 0.130 |
Why?
|
| Maternal-Fetal Relations | 1 | 2016 | 15 | 0.130 |
Why?
|
| Terminology as Topic | 2 | 2015 | 222 | 0.130 |
Why?
|
| Parturition | 1 | 2016 | 62 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 131 | 0.130 |
Why?
|
| New York | 1 | 2015 | 69 | 0.130 |
Why?
|
| Hypotension | 2 | 2016 | 185 | 0.120 |
Why?
|
| Bradycardia | 1 | 2016 | 61 | 0.120 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 254 | 0.120 |
Why?
|
| Congresses as Topic | 1 | 2016 | 173 | 0.120 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 219 | 0.120 |
Why?
|
| Pneumothorax | 1 | 2016 | 77 | 0.120 |
Why?
|
| Reproduction | 1 | 2017 | 237 | 0.120 |
Why?
|
| Zika Virus Infection | 1 | 2017 | 170 | 0.120 |
Why?
|
| Thrombocytopenia | 1 | 2016 | 221 | 0.120 |
Why?
|
| Hemorrhage | 2 | 2021 | 467 | 0.110 |
Why?
|
| Cephalosporins | 1 | 2015 | 137 | 0.110 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 2014 | 5 | 0.110 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 151 | 0.110 |
Why?
|
| Transportation of Patients | 1 | 2014 | 59 | 0.110 |
Why?
|
| Menstrual Cycle | 1 | 2013 | 34 | 0.110 |
Why?
|
| Patient Admission | 1 | 2014 | 186 | 0.110 |
Why?
|
| Asphyxia Neonatorum | 1 | 2013 | 15 | 0.110 |
Why?
|
| Hospital Mortality | 1 | 2018 | 1021 | 0.100 |
Why?
|
| Triage | 1 | 2014 | 138 | 0.100 |
Why?
|
| Disease Management | 1 | 2016 | 523 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 292 | 0.100 |
Why?
|
| Plasma | 3 | 2019 | 98 | 0.100 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 626 | 0.100 |
Why?
|
| Costs and Cost Analysis | 1 | 2013 | 164 | 0.100 |
Why?
|
| Uterine Inertia | 1 | 2012 | 4 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2014 | 383 | 0.100 |
Why?
|
| Oliguria | 1 | 2012 | 19 | 0.100 |
Why?
|
| Furosemide | 1 | 2012 | 38 | 0.100 |
Why?
|
| Contraindications | 1 | 2012 | 78 | 0.100 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2015 | 794 | 0.100 |
Why?
|
| Pregnancy, Prolonged | 1 | 2011 | 3 | 0.100 |
Why?
|
| Workload | 1 | 2013 | 145 | 0.100 |
Why?
|
| Decision Making | 1 | 2017 | 655 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1089 | 0.090 |
Why?
|
| ROC Curve | 2 | 2019 | 569 | 0.090 |
Why?
|
| Misoprostol | 2 | 2009 | 26 | 0.090 |
Why?
|
| Medical Audit | 1 | 2012 | 102 | 0.090 |
Why?
|
| Tennessee | 1 | 2011 | 27 | 0.090 |
Why?
|
| Tocolysis | 1 | 2011 | 5 | 0.090 |
Why?
|
| Angiography | 1 | 2012 | 215 | 0.090 |
Why?
|
| Tocolytic Agents | 1 | 2011 | 12 | 0.090 |
Why?
|
| Chest Pain | 1 | 2012 | 126 | 0.090 |
Why?
|
| Respiratory Tract Diseases | 1 | 2011 | 75 | 0.090 |
Why?
|
| Anticonvulsants | 2 | 2020 | 375 | 0.090 |
Why?
|
| Diuretics | 1 | 2012 | 171 | 0.090 |
Why?
|
| Dyspnea | 1 | 2012 | 152 | 0.090 |
Why?
|
| Urinary Tract Infections | 1 | 2015 | 302 | 0.090 |
Why?
|
| Morbidity | 1 | 2011 | 247 | 0.090 |
Why?
|
| Neonatology | 1 | 2011 | 53 | 0.090 |
Why?
|
| Jaundice, Neonatal | 1 | 2010 | 11 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 1428 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2010 | 1014 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 218 | 0.080 |
Why?
|
| Cholecystitis | 1 | 2009 | 20 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2014 | 848 | 0.080 |
Why?
|
| Pneumonia | 2 | 2011 | 323 | 0.080 |
Why?
|
| Puerperal Disorders | 1 | 2009 | 45 | 0.080 |
Why?
|
| Utah | 2 | 2006 | 47 | 0.080 |
Why?
|
| Bilirubin | 1 | 2010 | 123 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2018 | 12322 | 0.080 |
Why?
|
| Platelet Transfusion | 2 | 2019 | 53 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 587 | 0.080 |
Why?
|
| Uterine Rupture | 1 | 2009 | 18 | 0.080 |
Why?
|
| Adolescent | 4 | 2020 | 19279 | 0.080 |
Why?
|
| Neonatal Screening | 1 | 2010 | 184 | 0.070 |
Why?
|
| Appendicitis | 1 | 2009 | 126 | 0.070 |
Why?
|
| Patient Readmission | 2 | 2009 | 384 | 0.070 |
Why?
|
| Blood Volume | 1 | 2008 | 80 | 0.070 |
Why?
|
| Middle Aged | 4 | 2020 | 26714 | 0.070 |
Why?
|
| Hospitals, Proprietary | 1 | 2007 | 2 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2012 | 490 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2017 | 1178 | 0.070 |
Why?
|
| Factor VIII | 2 | 2019 | 45 | 0.060 |
Why?
|
| Oxygen Consumption | 1 | 2007 | 305 | 0.060 |
Why?
|
| Fibrinogen | 2 | 2019 | 154 | 0.060 |
Why?
|
| Male | 6 | 2024 | 61191 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 4350 | 0.060 |
Why?
|
| Uterus | 1 | 2009 | 569 | 0.060 |
Why?
|
| Critical Care | 1 | 2010 | 657 | 0.060 |
Why?
|
| Transfusion Reaction | 2 | 2015 | 42 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2091 | 0.050 |
Why?
|
| Logistic Models | 2 | 2019 | 1805 | 0.050 |
Why?
|
| Animals | 3 | 2014 | 34072 | 0.050 |
Why?
|
| Emergencies | 2 | 2017 | 171 | 0.050 |
Why?
|
| Meconium | 1 | 2002 | 11 | 0.050 |
Why?
|
| Developed Countries | 1 | 2003 | 37 | 0.050 |
Why?
|
| Infant Welfare | 1 | 2002 | 28 | 0.050 |
Why?
|
| Maternal Welfare | 1 | 2002 | 14 | 0.050 |
Why?
|
| Anesthesia, Epidural | 1 | 2002 | 14 | 0.050 |
Why?
|
| Pelvis | 1 | 2022 | 71 | 0.050 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2002 | 33 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 2154 | 0.050 |
Why?
|
| Infant | 1 | 2016 | 12468 | 0.050 |
Why?
|
| Fertilization | 1 | 2021 | 42 | 0.050 |
Why?
|
| Blood Coagulation Tests | 1 | 2021 | 61 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 2891 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2003 | 510 | 0.040 |
Why?
|
| Causality | 1 | 2020 | 83 | 0.040 |
Why?
|
| Placentation | 1 | 2020 | 55 | 0.040 |
Why?
|
| Thrombelastography | 1 | 2021 | 57 | 0.040 |
Why?
|
| Texas | 2 | 2020 | 3583 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2020 | 1254 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2003 | 371 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2024 | 443 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2020 | 107 | 0.040 |
Why?
|
| Hemoglobin A | 1 | 2019 | 22 | 0.040 |
Why?
|
| Exome | 1 | 2024 | 1034 | 0.040 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2019 | 67 | 0.040 |
Why?
|
| Acid-Base Imbalance | 1 | 2019 | 27 | 0.040 |
Why?
|
| Acid-Base Equilibrium | 1 | 2019 | 59 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 136 | 0.040 |
Why?
|
| Live Birth | 1 | 2018 | 55 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 307 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2003 | 437 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 680 | 0.040 |
Why?
|
| Placenta, Retained | 1 | 2017 | 12 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 5145 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2017 | 95 | 0.030 |
Why?
|
| Research | 1 | 2019 | 263 | 0.030 |
Why?
|
| Inservice Training | 1 | 2017 | 55 | 0.030 |
Why?
|
| Isotonic Solutions | 1 | 2017 | 35 | 0.030 |
Why?
|
| Parity | 1 | 2017 | 78 | 0.030 |
Why?
|
| Gravidity | 1 | 2016 | 10 | 0.030 |
Why?
|
| Breech Presentation | 1 | 2016 | 20 | 0.030 |
Why?
|
| Population | 1 | 2016 | 21 | 0.030 |
Why?
|
| Family | 1 | 2019 | 562 | 0.030 |
Why?
|
| Prevalence | 1 | 2003 | 2445 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2019 | 227 | 0.030 |
Why?
|
| Length of Stay | 1 | 2002 | 1310 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2019 | 281 | 0.030 |
Why?
|
| Seizures | 1 | 2020 | 874 | 0.030 |
Why?
|
| Hemostatics | 1 | 2015 | 57 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 1177 | 0.030 |
Why?
|
| Fluid Therapy | 1 | 2015 | 125 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2019 | 436 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2876 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 518 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1052 | 0.030 |
Why?
|
| Microcephaly | 1 | 2017 | 330 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2020 | 722 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 368 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 3153 | 0.030 |
Why?
|
| Resuscitation | 1 | 2015 | 250 | 0.030 |
Why?
|
| Regional Medical Programs | 1 | 2012 | 16 | 0.030 |
Why?
|
| Patient Discharge | 2 | 2010 | 489 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 1231 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2012 | 212 | 0.020 |
Why?
|
| Probability | 2 | 2002 | 320 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 2011 | 46 | 0.020 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2012 | 121 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2011 | 199 | 0.020 |
Why?
|
| Phototherapy | 1 | 2010 | 34 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2012 | 327 | 0.020 |
Why?
|
| Prostaglandins | 1 | 2009 | 48 | 0.020 |
Why?
|
| Peer Review, Health Care | 1 | 2009 | 17 | 0.020 |
Why?
|
| Hematocrit | 1 | 2008 | 111 | 0.020 |
Why?
|
| Lacerations | 1 | 2008 | 34 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2006 | 127 | 0.020 |
Why?
|
| Heart Failure | 1 | 2019 | 2283 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2006 | 275 | 0.020 |
Why?
|
| Asthma | 1 | 2011 | 749 | 0.010 |
Why?
|
| Goats | 1 | 2002 | 55 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2002 | 89 | 0.010 |
Why?
|
| Cervical Ripening | 1 | 2002 | 7 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 1108 | 0.010 |
Why?
|
| Child | 1 | 2022 | 24374 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2002 | 284 | 0.010 |
Why?
|
| Hospital Costs | 1 | 2002 | 179 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 711 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2002 | 475 | 0.010 |
Why?
|